Literature DB >> 18202206

Executive functions are impaired in patients with Parkinson's disease with visual hallucinations.

J Barnes1, L Boubert.   

Abstract

OBJECTIVES: Although cognitive impairment has been identified as a risk factor for visual hallucinations (VHs), more specific neuropsychological deficits underlying such phenomena have not been established. Here, we investigate the link between executive dysfunction and the occurrence of VHs.
METHODS: We evaluated three groups--17 patients with Parkinson's disease (PD) with VHs, 20 patients with PD without VHs and 20 age-matched controls--on a battery of tests previously reported to evaluate executive functions, namely tests of inhibitory ability, short-term memory and working memory.
RESULTS: Differences were found on tests of inhibitory ability, for which the patient group with VHs showed impairment when compared with the non-hallucinating group.
CONCLUSIONS: Patients with PD with VHs have substantially greater impairment of inhibitory ability than patients without VHs. These findings support interactive models of the genesis of visual hallucinations in PD.

Entities:  

Mesh:

Year:  2008        PMID: 18202206     DOI: 10.1136/jnnp.2007.116202

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Advances in the treatment of visual hallucinations in neurodegenerative diseases.

Authors:  Daniel Collerton; John-Paul Taylor
Journal:  Future Neurol       Date:  2013-07

Review 2.  Auditory hallucinations in schizophrenia and nonschizophrenia populations: a review and integrated model of cognitive mechanisms.

Authors:  Flavie Waters; Paul Allen; André Aleman; Charles Fernyhough; Todd S Woodward; Johanna C Badcock; Emma Barkus; Louise Johns; Filippo Varese; Mahesh Menon; Ans Vercammen; Frank Larøi
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

Review 3.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

4.  Treatment of psychosis and dementia in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

5.  Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.

Authors:  Carmen Gasca-Salas; Pedro Clavero; David García-García; José A Obeso; María C Rodríguez-Oroz
Journal:  Hum Brain Mapp       Date:  2015-12-14       Impact factor: 5.038

6.  Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease.

Authors:  James M Shine; Joanna M Z Mills; Jessica Qiu; Claire O'Callaghan; Zoe Terpening; Glenda M Halliday; Sharon L Naismith; Simon J G Lewis
Journal:  Mov Disord Clin Pract       Date:  2015-03-16

Review 7.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

8.  Relationship of Movement Disorders Society-Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease.

Authors:  Bryan A Bernard; Danielle Carns; Glenn T Stebbins; Jennifer G Goldman; Christopher G Goetz
Journal:  Mov Disord Clin Pract       Date:  2020-02-12

9.  Informant- and Self-Appraisals on the Psychosis and Hallucinations Questionnaire (PsycH-Q) Enhances Detection of Visual Hallucinations in Parkinson's Disease.

Authors:  Alana J Muller; Joanna M Z Mills; Claire O'Callaghan; Sharon L Naismith; Paul D Clouston; Simon J G Lewis; James M Shine
Journal:  Mov Disord Clin Pract       Date:  2018-11-08

10.  The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations.

Authors:  Sang Soo Cho; Antonio P Strafella; Sarah Duff-Canning; Mateusz Zurowski; Anne-Catherine Vijverman; Veronica Bruno; Camila C Aquino; Marion Criaud; Pablo M Rusjan; Sylvain Houle; Susan H Fox
Journal:  Mov Disord Clin Pract       Date:  2017-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.